Corcept Therapeutics
CORT • NASDAQ • Stock Fundamentals
Corcept Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph K. Belanoff, with a market cap of $8.9B.
Market Cap$8.9B
Employees352.0
CEOJoseph K. Belanoff
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsJul 30, 2026 · in a monthAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Corcept Therapeutics FAQ
Common questions about Corcept Therapeutics
Corcept Therapeutics (CORT) has a market capitalization of $8.9B and trades on NASDAQ.
Corcept Therapeutics has approximately 352 employees.